PRIMARY PURPOSE AND OVERALL IVE OF THE JOB:
1.Responsible for clinical trials, which requires technical specialization, the ability to interface with investigators/doctors
2.Summarize and share with RA group the CT study experience.

MAIN ACCOUNTABILITIES:
1.Ensure the implementation of project plans as assigned
2.Support clinical research manager in general study plan and protocol writing, data management and analysis, and final report writing
3.Support clinical research manager in study contract negotiation and signing, study problem solving and troubleshooting.
4.Take part in site ion and uation , site monitoring, site management, site close-out and registry management for clinical studies.
5.Manage study materials, including reagents ordering and storage, trial master file management, instrument setting-up, equipping & training sites
6.Ensure all clinical trials activities and documents are in compliance with local regulations, ICH GCP and company SOPs
7.Technical review to launch & close trials
8.Collaborate with investigators on scientific s & papers.

KNOWLEDGE, LANGUAGE AND EXPERIENCE:
1.MSc in a scientific field (biology, pharmacy), medical preferred
2.1-3 years’ clinical research experience in the relevant industry, IVD preferred
3.Good knowledge of clinical trial process
4.Good knowledge of GCP and ICH guidelines including basic understanding of regulatory requirements, China regulation understanding preferred
5.Basic knowledge of protocol and other record drafting
6.Chinese native speaker with fluent English in both written and oral

生物梅里埃公司創(chuàng)建于1963年，公司依賴自身的科技研究和工業(yè)生產(chǎn)資源，始終致力于開(kāi)發(fā)作為醫(yī)療和工業(yè)用途的體外診斷產(chǎn)品。 集團(tuán)專門(mén)設(shè)計(jì)、開(kāi)發(fā)、生產(chǎn)和推廣應(yīng)用在臨床和工業(yè)的系統(tǒng)。生物梅里埃的診斷系統(tǒng)是由試劑、 儀器和軟件組成，主要是為傳染病、工業(yè)微生物控制、心血管病和腫瘤病等四個(gè)主要策略性領(lǐng)域來(lái)設(shè)計(jì)。

在2008年，公司銷(xiāo)售額為11億1千1百萬(wàn)歐元，集團(tuán)共有11個(gè)生產(chǎn)基地和9個(gè)研究中心，分布于歐洲、北美洲和南美洲。集團(tuán)全球擁有38個(gè)辦事處，至2008年12月31日集團(tuán)員工超過(guò)5,700人。

生物梅里埃公司產(chǎn)品有兩個(gè)應(yīng)用領(lǐng)域 : 臨床和工業(yè)，臨床市場(chǎng)占總銷(xiāo)售額的85.5%，而工業(yè)市場(chǎng)占14.5%。工業(yè)的應(yīng)用主要在食品、藥品和化妝品的微生物分析，增長(zhǎng)非常迅速，生物梅里埃是全球體外診斷領(lǐng)域的第八大生產(chǎn)商。

生物梅里埃中國(guó)有限公司已經(jīng)20年的發(fā)展，自動(dòng)化微生物鑒定分析系統(tǒng)的用戶已達(dá)1400余家，自動(dòng)微生物培養(yǎng)系統(tǒng)已達(dá)700余家，全自動(dòng)細(xì)菌計(jì)數(shù)系統(tǒng)60余臺(tái)，手工產(chǎn)品用戶覆蓋全國(guó)的省市70%以上。同時(shí)公司擁有數(shù)十名微生物臨床及工業(yè)領(lǐng)域?qū)I(yè)人員和工程技術(shù)人員，其中許多人員都來(lái)自檢驗(yàn)一線，擁有豐富的檢驗(yàn)經(jīng)驗(yàn)和儀器維修經(jīng)驗(yàn)。全面負(fù)責(zé)生物梅里埃公司產(chǎn)品的銷(xiāo)售，儀器的安裝、維護(hù)及保養(yǎng)，以及用戶的培訓(xùn)及技術(shù)支持。